Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2-year real-life study

被引：3
|
作者：
Di Bona, Danilo [1 ]
Nettis, Eustachio [1 ]
Minenna, Elena [2 ]
Lovecchio, Antonella [1 ]
Paolino, Donato [1 ]
Cristina Nizi, Maria [3 ]
Albanesi, Marcello [1 ]
Ridolo, Erminia [3 ]
Filomena Caiaffa, Maria [2 ]
Macchia, Luigi [1 ]
机构：
[1] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sch & Chair Allergol & Clin Immunol, Piazza Giulio Cesare 11, I-70124 Bari, Italy
[2] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[3] Univ Parma, Med & Surg Dept, Allergy & Clin Immunol, Parma, Italy
来源：
ALLERGY | 2020年 / 75卷 / 10期
关键词：
URTICARIA;
D O I：
10.1111/all.14341
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2681 / 2684
页数：4
相关论文
共 50 条
  • [21] Omalizumab is effective in nasal polyposis with or without asthma, a real-life study
    Tat, Tugba Songul
    WORLD ALLERGY ORGANIZATION JOURNAL, 2022, 15 (08):
  • [22] "Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma
    Al-Ahmad, Mona
    Arifhodzic, Nermina
    Nurkic, Jasmina
    Maher, Ahmed
    Rodriguez-Bouza, Tito
    Al-Ahmed, Nasser
    Sadek, Ali
    Jusufovic, Edin
    MEDICAL PRINCIPLES AND PRACTICE, 2018, 27 (03) : 260 - 266
  • [23] Real-life efficacy and safety of secukinumab in elderly patients with psoriasis over a 2-year period
    Megna, M.
    Camela, E.
    Cinelli, E.
    Fabbrocini, G.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2020, 45 (07) : 848 - 852
  • [24] Efficacy and discontinuation of nabiximols in patients with multiple sclerosis: a real-life study
    Bergamaschi, V.
    Konrad, G.
    Battaglia, M. A.
    Brichetto, G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 959 - 959
  • [25] 2-YEAR FOLLOW-UP OF COPD PATIENTS IN THE NON-INTERVENTIONAL 'REAL-LIFE' DACCORD STUDY IN GERMANY
    Worth, H.
    Buhl, R.
    Criee, C. P.
    Kardos, P.
    Mailaender, C.
    Lossi, N.
    Vogelmeier, C.
    THORAX, 2016, 71 : A159 - A159
  • [26] Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study
    Megna, Matteo
    Ruggiero, Angelo
    Battista, Teresa
    Marano, Laura
    Cacciapuoti, Sara
    Potestio, Luca
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [27] Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study
    Fiocchi, Alessandro
    Artesani, Maria Cristina
    Riccardi, Carla
    Mennini, Maurizio
    Pecora, Valentina
    Fierro, Vincenzo
    Calandrelli, Veronica
    Dahdah, Lamia
    Valluzzi, Rocco Luigi
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06): : 1901 - +
  • [28] Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
    Garcia-Gomez, Elizabeth
    Chapman, Edgardo
    Garcia-Paba, Maria Beatriz
    Ocampo-Gomez, Jaime
    Egea-Bermejo, Eduardo
    Garavito-De Egea, Gloria
    Fang, Luis
    Sarrazola, Mauricio
    Sanchez-Caraballo, Jorge Mario
    Serrano-Reyes, Carlos
    Silva-Espinosa, Diana Lucia
    Rojas-Mejia, Dolly Vanessa
    Moreno, Sergio M.
    FRONTIERS IN ALLERGY, 2022, 3
  • [29] Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
    Solidoro, Paolo
    Patrucco, Filippo
    de Blasio, Francesca
    Brussino, Luisa
    Bellocchia, Michela
    Dassetto, Davide
    Pivetta, Emanuele
    Riccio, Annamaria
    Heffler, Enrico
    Canonica, Walter
    Rolla, Giovanni
    Bucca, Caterina
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [30] Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study
    Ramsey, Nicole B.
    Sicherer, Scott
    PEDIATRICS, 2020, 146 : S354 - S355
12345